Sandra Silberman
Director Técnico/Científico/I+D en MOLECULIN BIOTECH, INC. .
Fortuna: 53 $ al 30/04/2024
Cargos activos de Sandra Silberman
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| MOLECULIN BIOTECH, INC. | Director Técnico/Científico/I+D | 08/11/2017 | - |
| CNS PHARMACEUTICALS, INC. | Director Técnico/Científico/I+D | 01/12/2017 | - |
Historial de carrera de Sandra Silberman
Antiguos cargos conocidos de Sandra Silberman.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| Eisai Medical Research, Inc. | Corporate Officer/Principal | 01/01/2004 | - |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Director Técnico/Científico/I+D | 01/01/2000 | - |
| SCORPIUS HOLDINGS, INC. | Director Técnico/Científico/I+D | 01/01/2013 | - |
Formación de Sandra Silberman.
| Weill Cornell Medical College | Doctorate Degree |
| Zanvyl Krieger School of Arts & Sciences | Undergraduate Degree |
| The Johns Hopkins University School of Medicine | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 9 |
Operativa
| Chief Tech/Sci/R&D Officer | 4 |
| Doctorate Degree | 2 |
| Corporate Officer/Principal | 1 |
Sectorial
| Health Technology | 5 |
| Consumer Services | 4 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| SCORPIUS HOLDINGS, INC. | Health Technology |
| MOLECULIN BIOTECH, INC. | Health Technology |
| CNS PHARMACEUTICALS, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Health Technology |
| Eisai Medical Research, Inc. |
- Bolsa de valores
- Insiders
- Sandra Silberman
- Experiencia
